Proteomics International is a medical technology company at the forefront of predictive diagnostics and bioanalytical services.
The company specialises in the area of proteomics - the industrial scale study of the structure and function of proteins. It received the world's first ISO 17025 laboratory accreditation for proteomics services. The company's operations centre on the commercialisation of its world-leading test for diabetic kidney disease, PromarkerD, whilst using its proprietary technology platform to develop new diagnostic tests, provide analytical and pharmacokinetic services.
Visit Proteomics International for more information.
Contact: J. Chuck Morrison, Head of Business Development at email@example.com